Official reprint from UpToDate
©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.
Medline ® Abstract for Reference 53
of 'Clinical use of tyrosine kinase inhibitors for chronic myeloid leukemia'
Dasatinib (Sprycel) for CML and Ph + ALL.
Med Lett Drugs Ther. 2007;49(1252):6.